Market Cap 32.95M
Revenue (ttm) 0.00
Net Income (ttm) -83.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.09
Volume 33,958
Avg Vol 27,806
Day's Range N/A - N/A
Shares Out 7.31M
Stochastic %K 7%
Beta 0.61
Analysts Strong Sell
Price Target $12.50

Latest News on KZR

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Oct 28, 2024, 8:30 AM EDT - 5 months ago

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split


Kezar Life Sciences halts mid-stage trial for lupus treatment

Sep 30, 2024, 8:46 AM EDT - 6 months ago

Kezar Life Sciences halts mid-stage trial for lupus treatment


Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023

Mar 6, 2023, 7:00 AM EST - 2 years ago

Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023


Kezar Life Sciences: Regulatory Tailwinds Reverse Downside Case

Jul 27, 2022, 1:45 PM EDT - 2 years ago

Kezar Life Sciences: Regulatory Tailwinds Reverse Downside Case